{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:17:18Z","timestamp":1788304638489,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hlc.2026.01.018","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:42:05Z","timestamp":1781901725000},"page":"1214-1223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coagulopathy in Cardiac Surgery: A Scoping Review of Prothrombin Complex Concentrate"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1888-0408","authenticated-orcid":false,"given":"Stanislaw","family":"Vander Zwaag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2995-4042","authenticated-orcid":false,"given":"Imre","family":"Kukel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Fassl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2026.01.018_bib1","article-title":"Effect of cardiopulmonary bypass on coagulation factors II, VII and X in a primate model: an exploratory pilot study","volume":"37","author":"Shimoda","year":"2023","journal-title":"Interdiscip CardioVasc Thorac Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/bja\/aen391","article-title":"Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model","volume":"102","author":"Dickneite","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib3","first-page":"391","article-title":"Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates","volume":"11","author":"Caballo","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.hlc.2026.01.018_bib4","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2025.3501","article-title":"Prothrombin complex concentrate vs frozen plasma for coagulopathic bleeding in cardiac surgery: the FARES-II multicenter randomized clinical trial","volume":"333","author":"Karkouti","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.01.018_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11239-024-03061-3","article-title":"Thrombin generation after prothrombin complex concentrate or plasma transfusion during cardiac surgery","volume":"58","author":"Welsby","year":"2025","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.hlc.2026.01.018_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.24758","article-title":"Vitamin K antagonist reversal for urgent surgery using 4-factor prothrombin complex concentrates: a randomized clinical trial","volume":"7","author":"Sarode","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hlc.2026.01.018_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3936","article-title":"Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial","volume":"4","author":"Karkouti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hlc.2026.01.018_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-015-1172-6","article-title":"Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery","volume":"20","author":"Cappabianca","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2026.01.018_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/icvts\/ivs224","article-title":"Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery","volume":"15","author":"Arn\u00e9kian","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/08971900241228766","article-title":"Comparison of low dose recombinant factor VIIa and 4-factor prothrombin complex concentrate for treatment of bleeding related to cardiac surgery","volume":"37","author":"Caldwell","year":"2024","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.hlc.2026.01.018_bib11","article-title":"Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding","volume":"11","author":"Hayes","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hlc.2026.01.018_bib12","doi-asserted-by":"crossref","DOI":"10.21470\/1678-9741-2023-0076","article-title":"Hemostasis using prothrombin complex concentrate in patients undergoing cardiac surgery: systematic review with meta-analysis","volume":"39","author":"Li","year":"2024","journal-title":"Braz J Cardiovasc Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1053\/j.jvca.2024.03.011","article-title":"Methodologic quality and pharmacotherapy recommendations for patient blood management guidelines for cardiac surgery on cardiopulmonary bypass","volume":"38","author":"Huang","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.hlc.2018.10.025","article-title":"Comparative analysis of prothrombin complex concentrate and fresh frozen plasma in coronary surgery","volume":"28","author":"Biancari","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.018_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bja.2018.02.017","article-title":"Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: a propensity score matched comparison to plasma","volume":"120","author":"Fitzgerald","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamasurg.2022.2235","article-title":"Prothrombin complex concentrate vs plasma for post-cardiopulmonary bypass coagulopathy and bleeding: a randomized clinical trial","volume":"157","author":"Smith","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.athoracsur.2018.10.013","article-title":"Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis","volume":"107","author":"Roman","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5090\/jcs.23.081","article-title":"Prothrombin complex concentrate versus fresh frozen plasma in adult patients undergoing cardiac surgery: a systematic review and meta-analysis","volume":"57","author":"Viana","year":"2024","journal-title":"J Chest Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s12630-021-02100-4","article-title":"FIBRES study investigators. FIBRES study investigators. The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial","volume":"68","author":"Bartoszko","year":"2021","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.jvca.2017.07.011","article-title":"Outcomes following three-factor inactive prothrombin complex concentrate versus recombinant activated factor VII administration during cardiac surgery","volume":"32","author":"Harper","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib21","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1111\/aor.13918","article-title":"Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation","volume":"45","author":"Boswell","year":"2021","journal-title":"Artif Organs"},{"key":"10.1016\/j.hlc.2026.01.018_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.ccm.0000550849.34347.6f","article-title":"Effect of 4-factor PCC reversal protocol in LVAD patients undergoing heart transplantation","volume":"47","author":"Wong","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1423-0410.2010.01339.x","article-title":"Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study","volume":"99","author":"Demeyere","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.hlc.2026.01.018_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jemermed.2019.10.013","article-title":"Prospective evaluation of a fixed-dose 4-factor prothrombin complex concentrate protocol for urgent vitamin K antagonist reversal","volume":"58","author":"Bitonti","year":"2020","journal-title":"J Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajem.2021.05.023","article-title":"Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal","volume":"48","author":"Stoecker","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajem.2023.11.066","article-title":"Safety and efficacy of fixed versus variable-dose prothrombin complex concentrate for emergent reversal of vitamin K antagonists: a systematic review and meta-analysis","volume":"77","author":"Condeni","year":"2024","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3324\/haematol.2012.063701","article-title":"An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies","volume":"97","author":"Khorsand","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.hlc.2026.01.018_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/acem.12911","article-title":"Safety of a four-factor prothrombin complex concentrate versus plasma for vitamin K antagonist reversal: an integrated analysis of two phase IIIb clinical trials","volume":"23","author":"Milling","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annemergmed.2021.06.016","article-title":"Fixed versus variable dosing of prothrombin complex concentrate for bleeding complications of vitamin K antagonists-the PROPER3 randomized clinical trial","volume":"79","author":"Abdoellakhan","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajem.2021.06.032","article-title":"Fixed-dose prothrombin complex concentrate for emergent warfarin reversal among patients with intracranial hemorrhage","volume":"49","author":"Dietrich","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.15441\/ceem.24.265","article-title":"Comparison of 4-factor fixed-dose versus 4-factor weight-based dose prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis","volume":"12","author":"Alrashed","year":"2025","journal-title":"Clin Exp Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10557-021-07192-0","article-title":"Efficacy and safety of the fixed-dose versus variable-dose of 4-PCC for vitamin K antagonist reversal: a comprehensive systematic review and meta-analysis","volume":"36","author":"Mohammadi","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hlc.2026.01.018_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0000000000006212","article-title":"Fixed- versus variable-dose prothrombin complex concentrate for the emergent reversal of vitamin K antagonists: a systematic review and meta-analysis","volume":"52","author":"Alwakeal","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib34","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/bloodadvances.2022009015","article-title":"INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma","volume":"7","author":"Hood","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.hlc.2026.01.018_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00540-015-2128-3","article-title":"Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery","volume":"30","author":"Tanaka","year":"2016","journal-title":"J Anesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib36","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s12630-020-01609-4","article-title":"Thrombin generation and bleeding in cardiac surgery: a clinical narrative review","volume":"67","author":"Fitzgerald","year":"2020","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MBC.0000000000000887","article-title":"Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: a comparison between 3-factor and 4-factor prothrombin complex concentrates","volume":"31","author":"Spiezia","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.hlc.2026.01.018_bib38","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1515\/cclm-2014-0877","article-title":"INR vs. thrombin generation assays for guiding VKA reversal: a retrospective comparison","volume":"53","author":"Herpers","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezae352","article-title":"2024 EACTS\/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP","volume":"67","author":"Casselman","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2026.01.018_bib40","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s11239-021-02480-w","article-title":"Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis","volume":"52","author":"Milioglou","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.hlc.2026.01.018_bib41","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jth.13815","article-title":"Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study","volume":"15","author":"Song","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241243368","article-title":"Comparison of fixed versus weight-based prothrombin complex concentrate dosing strategies for factor Xa inhibitor reversal","volume":"30","author":"Brett","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0885066618800657","article-title":"Evaluation of the use of low-dose 4-factor prothrombin complex concentrate in the reversal of direct oral anticoagulants in bleeding patients","volume":"35","author":"Allison","year":"2020","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib44","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/trf.15259","article-title":"Idarucizumab, but not procoagulant concentrates, fully restores dabigatran-altered platelet and fibrin components of hemostasis","volume":"59","author":"Arellano-Rodrigo","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.hlc.2026.01.018_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bjh.13821","article-title":"In vivo reversal of the anticoagulant effect of Rivaroxaban with four-factor prothrombin complex concentrate","volume":"172","author":"Barco","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hlc.2026.01.018_bib46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/jth.13115","article-title":"In vivo increase in thrombin generation by four-factor prothrombin complex concentrate in apixaban-treated healthy volunteers","volume":"13","author":"Cheung","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cts.12398","article-title":"Reversibility of apixaban anticoagulation with a four-factor prothrombin complex concentrate in healthy volunteers","volume":"9","author":"Nagalla","year":"2016","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.hlc.2026.01.018_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bja.2023.10.018","article-title":"Comparative analysis of andexanet alfa and prothrombin complex concentrate in reversing anticoagulation by Rivaroxaban ex vivo","volume":"132","author":"Rayatdoost","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12873-022-00568-x","article-title":"Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis","volume":"22","author":"Margraf","year":"2022","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib50","first-page":"877","article-title":"Comparison between prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) for the urgent reversal of warfarin in patients with mechanical heart valves in a tertiary care cardiac center","volume":"14","author":"Fariborz Farsad","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.hlc.2026.01.018_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1213\/ane.0b013e3181608f7c","article-title":"Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass","volume":"106","author":"Sniecinski","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.hlc.2026.01.018_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/anae.15181","article-title":"A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients","volume":"76","author":"Erdoes","year":"2021","journal-title":"Anaesthesia"},{"key":"10.1016\/j.hlc.2026.01.018_bib53","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1053\/j.jvca.2019.04.003","article-title":"Society of Cardiovascular Anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients","volume":"33","author":"Raphael","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12624","article-title":"Comparison of 4F-PCC in obese and nonobese patients with life-threatening bleeding or requiring emergent surgery","volume":"5","author":"Rimsans","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12028-018-0606-9","article-title":"Abstracts presented at the neurocritical care society (NCS) 16th annual meeting","volume":"29","author":"Smetana","year":"2018","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.hlc.2026.01.018_bib56","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-0038-1636541","article-title":"Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: a prospective cohort study","volume":"118","author":"Schulman","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0885066620984443","article-title":"A comparison of prothrombin complex concentrate and recombinant activated factor VII for the management of bleeding with cardiac surgery","volume":"37","author":"Katz","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib58","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/cc6987","article-title":"Prothrombin complex concentrate (Beriplex P\/N) in severe bleeding: experience in a large tertiary hospital","volume":"12","author":"Bruce","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2026.01.018_bib59","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/anae.15327","article-title":"Prothrombin complex concentrate vs. fresh frozen plasma in adult patients undergoing heart surgery - a pilot randomised controlled trial (PROPHESY trial)","volume":"76","author":"Green","year":"2021","journal-title":"Anaesthesia"},{"key":"10.1016\/j.hlc.2026.01.018_bib60","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.hlc.2022.05.048","article-title":"Immediate higher-dose prothrombin complex concentrate without fresh frozen plasma or fibrinogen concentrate for significant coagulopathic cardiac surgical field bleeding","volume":"31","author":"Pruthi","year":"2022","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.018_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2019.01.025","article-title":"Patient blood management in cardiac surgery: the \u201cGranducato algorithm\u201d","volume":"289","author":"Scolletta","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2026.01.018_bib62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1060028017752365","article-title":"Activated factor 7 versus 4-factor prothrombin complex concentrate for critical bleeding post-cardiac surgery","volume":"52","author":"Mehringer","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hlc.2026.01.018_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1213\/ANE.0000000000000689","article-title":"An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery","volume":"121","author":"Ortmann","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.hlc.2026.01.018_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MBC.0000000000000243","article-title":"Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass","volume":"26","author":"Percy","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.hlc.2026.01.018_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2025.104115","article-title":"Twenty years of the four-factor prothrombin complex concentrate Octaplex\/Balfaxar: a narrative review","volume":"64","author":"Karkouti","year":"2025","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.hlc.2026.01.018_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bja.2024.09.028","article-title":"Comparison of ROTEM\u00ae Delta and ROTEM\u00ae Sigma transfusion algorithm performance in thoracic aortic surgery: a single-centre prospective observational cohort study","volume":"134","author":"van Haeren","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib67","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.jvca.2017.12.044","article-title":"A comparative study of point-of-care prothrombin time in cardiopulmonary bypass surgery","volume":"32","author":"Okabayashi","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.hlc.2026.01.018_bib68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ACO.0000000000001464","article-title":"Restoring hemostasis with prothrombin complex concentrate: benefits and risks in trauma-induced coagulopathy","volume":"38","author":"Grottke","year":"2025","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.hlc.2026.01.018_bib69","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.hlc.2024.01.010","article-title":"Implementation of patient blood management in orthotopic heart transplants: a single centre retrospective observational review","volume":"33","author":"Rapier","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.018_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13049-015-0165-4","article-title":"Effect of coagulation factor concentrate administration on ROTEM\u00ae parameters in major trauma","volume":"23","author":"Ponschab","year":"2015","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib71","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.3390\/jcm13237137","article-title":"Fibrinogen and prothrombin complex concentrate: the importance of the temporal sequence-a post-hoc analysis of two randomized controlled trials","volume":"13","author":"Ranucci","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2026.01.018_bib72","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1097\/MJT.0000000000000643","article-title":"Comparison of 3-factor versus 4-factor prothrombin complex concentrate with regard to warfarin reversal, blood product use, and costs","volume":"25","author":"DeAngelo","year":"2018","journal-title":"Am J Ther"},{"key":"10.1016\/j.hlc.2026.01.018_bib73","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/trf.12110","article-title":"Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery","volume":"53","author":"Tanaka","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.hlc.2026.01.018_bib74","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1016\/j.clinthera.2011.01.011","article-title":"Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom","volume":"32","author":"Guest","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.hlc.2026.01.018_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11239-018-1653-y","article-title":"Fixed-dose 4-factor prothrombin complex concentrate: we don\u2019t know where we\u2019re going if we don\u2019t know how to get there","volume":"46","author":"Hall","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.hlc.2026.01.018_bib76","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/08971900241228779","article-title":"Hemostatic efficacy and safety of weight-based versus fixed-dose 4F-PCC for vitamin K antagonist reversal","volume":"37","author":"Milkovits","year":"2024","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.hlc.2026.01.018_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/cc13982","article-title":"Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients","volume":"18","author":"Sch\u00f6chl","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2026.01.018_bib78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0044-1788305","article-title":"Long-term safety of a four-factor prothrombin complex concentrate (Kcentra\u00ae\/Beriplex\u00ae P\/N): an updated pharmacovigilance review","volume":"125","author":"Milling","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib79","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/1076029617753537","article-title":"Retrospective review of a prothrombin complex concentrate (Beriplex P\/N) for the management of perioperative bleeding unrelated to oral anticoagulation","volume":"24","author":"Chowdary","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.hlc.2026.01.018_bib80","first-page":"1151","article-title":"Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model","volume":"68","author":"Dickneite","year":"2010","journal-title":"J Trauma"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626001903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626001903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:54:59Z","timestamp":1788303299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950626001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1443950626001903"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.018","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulopathy in Cardiac Surgery: A Scoping Review of Prothrombin Complex Concentrate","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}